Nanocarrier-mediated cancer therapy with cisplatin: <i>A meta-analysis with a promising new paradigm</i>.

ABSTRACT:

Aims

Cisplatin is a frontline chemotherapeutic utilized to attenuate multiple cancers in the clinic. Given its side-effects, a new cisplatin formulation which could prevent cytotoxicity, metabolic deficiencies and metastasis is much needed. This study investigates whether nanocarriers can provide a better mode of drug delivery in preclinical cancer models seeking a potent anticancer therapeutic agent.

Materials and methods

The PubMed database was searched, and 242 research articles were screened from which 94 articles qualified for selection from those published by December 31, 2023 and the data was synthesized using the Review Manager software.

Key findings

Cisplatin encapsulated as a nanomedicine confirmed the versatility of nanocarriers in significantly diminishing

SUBMITTER: Ranasinghe R 

PROVIDER: S-EPMC11747978 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature